224 related articles for article (PubMed ID: 32319885)
1. Partial loss of CFIm25 causes learning deficits and aberrant neuronal alternative polyadenylation.
Alcott CE; Yalamanchili HK; Ji P; van der Heijden ME; Saltzman A; Elrod N; Lin A; Leng M; Bhatt B; Hao S; Wang Q; Saliba A; Tang J; Malovannaya A; Wagner EJ; Liu Z; Zoghbi HY
Elife; 2020 Apr; 9():. PubMed ID: 32319885
[TBL] [Abstract][Full Text] [Related]
2. NUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylation.
Gennarino VA; Alcott CE; Chen CA; Chaudhury A; Gillentine MA; Rosenfeld JA; Parikh S; Wheless JW; Roeder ER; Horovitz DD; Roney EK; Smith JL; Cheung SW; Li W; Neilson JR; Schaaf CP; Zoghbi HY
Elife; 2015 Aug; 4():. PubMed ID: 26312503
[TBL] [Abstract][Full Text] [Related]
3. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
[TBL] [Abstract][Full Text] [Related]
4. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
[TBL] [Abstract][Full Text] [Related]
5. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
Masamha CP
Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
[TBL] [Abstract][Full Text] [Related]
7. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
[No Abstract] [Full Text] [Related]
8. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
Weng T; Huang J; Wagner EJ; Ko J; Wu M; Wareing NE; Xiang Y; Chen NY; Ji P; Molina JG; Volcik KA; Han L; Mayes MD; Blackburn MR; Assassi S
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757866
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
Xing Y; Chen L; Gu H; Yang C; Zhao J; Chen Z; Xiong M; Kazobinka G; Liu Y; Hou T
Oncogene; 2021 Mar; 40(11):2051-2064. PubMed ID: 33619322
[TBL] [Abstract][Full Text] [Related]
10. The role of NUDT21 in microRNA-binging sites of EZH2 gene increases the of risk preeclampsia.
Lang X; Zhao W; Huang D; Liu W; Shen H; Xu L; Xu S; Huang Y; Cheng W
J Cell Mol Med; 2019 May; 23(5):3202-3213. PubMed ID: 30883033
[TBL] [Abstract][Full Text] [Related]
11. Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling.
Brumbaugh J; Di Stefano B; Wang X; Borkent M; Forouzmand E; Clowers KJ; Ji F; Schwarz BA; Kalocsay M; Elledge SJ; Chen Y; Sadreyev RI; Gygi SP; Hu G; Shi Y; Hochedlinger K
Cell; 2018 Jan; 172(1-2):106-120.e21. PubMed ID: 29249356
[TBL] [Abstract][Full Text] [Related]
12. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
[TBL] [Abstract][Full Text] [Related]
13. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
[TBL] [Abstract][Full Text] [Related]
14. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
[TBL] [Abstract][Full Text] [Related]
15. NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
Jonnakuti VS; Ji P; Gao Y; Lin A; Chu Y; Elrod N; Huang KL; Li W; Yalamanchili HK; Wagner EJ
J Neurooncol; 2023 Jul; 163(3):623-634. PubMed ID: 37389756
[TBL] [Abstract][Full Text] [Related]
16. Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis.
Tan Y; Zheng T; Su Z; Chen M; Chen S; Zhang R; Wang R; Li K; Na N
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37737260
[TBL] [Abstract][Full Text] [Related]
17. CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis.
Ghosh S; Ataman M; Bak M; Börsch A; Schmidt A; Buczak K; Martin G; Dimitriades B; Herrmann CJ; Kanitz A; Zavolan M
Nucleic Acids Res; 2022 Apr; 50(6):3096-3114. PubMed ID: 35234914
[TBL] [Abstract][Full Text] [Related]
18. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
[TBL] [Abstract][Full Text] [Related]
19. Relationship between NUDT21 mediated alternative polyadenylation process and tumor.
Xiao S; Gu H; Deng L; Yang X; Qiao D; Zhang X; Zhang T; Yu T
Front Oncol; 2023; 13():1052012. PubMed ID: 36816917
[TBL] [Abstract][Full Text] [Related]
20. NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing.
Gao CC; Xu QQ; Xiao FJ; Wang H; Wu CT; Wang LS
Biochem Biophys Res Commun; 2020 May; 526(2):431-438. PubMed ID: 32228887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]